PAS
PJP icon

Park Avenue Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Park Avenue Securities’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,736
Closed -$515K – 19
2014
Q4 		$515K Buy
+7,736
New +$515K 0.13% 17

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
FIG
FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Park Avenue Securities's PJP Position: Q1 2015 in Review

Park Avenue Securities sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2015, closing a stake of 7,736 shares — an estimated $515K sold.

Park Avenue Securities first reported a position in PJP in Q4 2014 and held it in 1 quarter. The position peaked at $515K in Q4 2014. 105 funds tracked by Wall St. Rank hold PJP as of Q1 2015.

  • Park Avenue Securities reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2015 after selling out during the quarter.
  • Park Avenue Securities sold 7,736 Invesco Pharmaceuticals ETF shares in Q1 2015, an estimated $515K.
  • Park Avenue Securities first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and held it in 1 quarter.
  • Park Avenue Securities's Invesco Pharmaceuticals ETF position peaked at $515K in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2015.

Based on Park Avenue Securities's 13F filing for Q1 2015, filed 30 Apr 2015.